2024 annual financial data
Coya Therapeutics 2024 Operating margin
Coya Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -485.35%.
Operating income was -17,249,711 USD and net income was -14,880,787 USD.
Operating cash flow was -10,288,822 USD.
Get free Coya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,554,061 USD
- Operating income
- -17,249,711 USD
- Net income
- -14,880,787 USD
- Operating cash flow
- -10,288,822 USD